Skip to content

TIGMA

Active
Private limited company·Activiteiten van huisartspraktijken· 5 yrs active
Ruilare 126 ·9080 Lochristi, Belgium
KBO/BCE: BE 0768.900.093
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of TIGMA is 0.1% (very low). The 2025 annual accounts show equity of €2.24M and a net result of €552k. Equity is growing by ~31.4% per year across the filed fiscal years. Its solvency ranks better than 91% of 87 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 5 annual accounts.

Signals

3 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 91% of 87 peers (2025). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend
Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 21-01-2026, 10 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 5 filed financial years, each closing on 30-06. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 30-06-2025, that is 31-01-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
30-06-2025 31-01-2026 21-01-2026 10 d early 2026-00010907
30-06-2024 31-01-2025 31-01-2025 on the day 2025-00018953
30-06-2023 31-01-2024 19-12-2023 43 d early 2023-00530507
30-06-2022 31-01-2023 02-12-2022 60 d early 2022-20530298
30-06-2021 31-01-2022 17-01-2022 14 d early 2022-01000490

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€552k+68.1%
Working capital€2.19M+34.7%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 21-01-2026 with the NBB · fiscal year 2025 · verkort
€0€250k€500k€750kOperating result 2021: €642k€642kNet result 2021: €439k€439kOperating result 2022: €791k€791kNet result 2022: €546k€546kOperating result 2023: €544k€544kNet result 2023: €375k€375kOperating result 2024: €474k€474kNet result 2024: €328k€328kOperating result 2025: €801k€801kNet result 2025: €552k€552k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~31.4%/year over 5 fiscal years, indicative, assuming unchanged policy.
€0€1.00M€2.00M€3.00M€4.00M2026: €2.65M (€2.47M - €2.83M)2027: €3.08M (€2.90M - €3.26M)2028: €3.50M (€3.29M - €3.72M)2021: €444k2022: €990k2023: €1.36M2024: €1.69M2025: €2.24M20212022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency 95.2% 56.8%
better than 91% of 87 sector peers
Net result €552k €97k
better than 93% of 87 sector peers
Equity €2.24M €207k
better than 91% of 87 sector peers
Gross operating margin €819k €237k
better than 86% of 84 sector peers
Total assets €2.35M €591k
better than 85% of 87 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P91
2021: P67 · n=1542022: P94 · n=2602023: P95 · n=3452024: P95 · n=3822025: P91 · n=872021 2025
Stable position over 2021-2025 · n=87-382
Net result P93
2021: P92 · n=1532022: P95 · n=2562023: P90 · n=3392024: P85 · n=3722025: P93 · n=872021 2025
Stable position over 2021-2025 · n=87-372
Equity P91
2021: P64 · n=1542022: P85 · n=2602023: P89 · n=3452024: P92 · n=3822025: P91 · n=872021 2025
Improving position over 2021-2025 · n=87-382
Gross operating margin P86
2021: P79 · n=1482022: P90 · n=2532023: P82 · n=3342024: P75 · n=3722025: P86 · n=842021 2025
Stable position over 2021-2025 · n=84-372
Describes the position versus peers, not a forecast.
EBITDA
€817k
+69.9% 21-25
Net profit
€552k
+68.1% 21-25
Cash flow
€568k
+69.5% 21-25
Total assets
€2.35M
+37.9% 21-25
Equity
€2.24M
+32.4% 21-25
Working capital
€2.19M
+34.7% 21-25
Income taxes
€253k
+72.6% 21-25
Dividends
€3k
- 21-25
Debt
€112k
+687.4% 21-25
Debt ≤ 1y
€112k
+687.4% 21-25
Current ratio
20.48
-82.2% 21-25
Quick ratio
20.48
-82.2% 21-25
Solvency
95.2%
-4.0% 21-25
Debt / equity
0.05
+494.6% 21-25
ROE
24.6%
+26.9% 21-25
ROA
23.4%
+21.9% 21-25
Interest coverage
8623.36
+87.2% 21-25
Figures by fiscal year
Fiscal year2025
Depositverkort
Revenue-
EBITDA€817k
Net profit€552k
Cash flow€568k
Staff costs-
Income taxes€253k
Dividends€3k
Total assets€2.35M
Equity€2.24M
Debt€112k
of which ≤ 1y€112k
of which > 1y-
Working capital€2.19M
Employees (FTE)-
Ratios (computed)
2025
Current ratio20.48
Quick ratio20.48
Working capital ratio93.1%
Solvency95.2%
Debt / equity0.05
Long-term debt ratio-
Interest coverage8623.36
Gross margin-
Net margin-
ROA23.4%
ROE24.6%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€2.35M
Fixed assets 21/28€51k
Tangible fixed assets 22/27€51k
Current assets 29/58€2.30M
Amounts receivable within one year 40/41€477k
Cash & bank 54/58€1.82M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€2.35M
Equity 10/15€2.24M
Contributions / capital 10/11€717
Reserves 13€2.24M
Accumulated profits (losses) 14€0
Amounts payable 17/49€112k
Amounts payable within one year 42/48€112k
Trade debts payable within one year 44€9k
Income statement
Gross operating margin 9900€819k
Operating result 9901€801k
Financial income 75€4k
Financial charges 65€95
Result before taxes 9903€805k
Income taxes 67/77€253k
Net result for the period 9904€552k
Result to be appropriated 9905€552k
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap
3 companies at this address See who is registered here

Establishment units

1 location
TIGMA
Ruilare 126, 9080 LochristiActiviteiten van medische laboratoria
since 20212.325.597.269
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1,071 m²
Buildings1
Building footprint191 m²
Volume (LiDAR)1,382 m³
Tallest building11.3 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44077A0399/00G000 Flanders 1,071 m² 1 · 191 m² 11.3 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Huisartspraktijken86210Activiteiten van huisartspraktijken86210Activiteiten van medische beeldvorming en medische laboratoria86910Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL TIGMA
Registered office
Ruilare 126
9080 Lochristi, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.